Expanded Access to Everolimus for a Patient with Uterine Sarcoma

Sponsor: The University of Texas Health Science Center at San Antonio

Expanded Access

Sponsor score: 40

Inactive

ClinicalTrials ID:NCT03493165

This program provides access to the drug everolimus for a single patient with uterine sarcoma, a type of cancer that affects the uterus.

Patient Parameters

Parameter	Options

Program Overview

This program is designed to offer the drug everolimus to an individual patient who has uterine sarcoma. Everolimus is a medication that may help in managing this type of cancer. The program is specifically for one patient, allowing them to receive treatment with this drug under medical supervision.

Eligibility Criteria

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.